InflaRx IFRX
NASDAQ IFRX
$1.53 -0.02 (-1.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

InflaRx (IFRX) Asset Utilization Ratio (2024 - 2026)

Updated

InflaRx's Asset Utilization Ratio came in at 0.00 for Q2 2026, down 74.9% from 0.00 a year earlier.

Analysis

InflaRx (IFRX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

Going back to Q2 2024, InflaRx's Asset Utilization Ratio data covers 8 quarters.

  • Going back by year, Asset Utilization Ratio was 0.00 in FY2024 (+189.8%) and 0.00 in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Asset Utilization Ratio in data going back to Q2 2024.
  • Year-over-year, Asset Utilization Ratio increased in 1 of the last four quarters, with an average decline of 5.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.62
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.47
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.52
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.46
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.51
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.40
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.58
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 InflaRx 103.29 Mn -230.33 Mn 2.74 Mn 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
API Access

InflaRx Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IFRX&period=max&api_key=YOUR_API_KEY